These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6378594)

  • 21. Early detection of degraded A14-125I-insulin in human fibroblasts by the use of high performance liquid chromatography.
    Stentz FB; Harris HL; Kitabchi AE
    Diabetes; 1983 May; 32(5):474-7. PubMed ID: 6341131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of insulin degradation products generated in liver endosomes: in vivo and in vitro studies.
    Clot JP; Janicot M; Fouque F; Desbuquois B; Haumont PY; Lederer F
    Mol Cell Endocrinol; 1990 Sep; 72(3):175-85. PubMed ID: 2289630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation of insulin by trypsin and alpha-chymotrypsin.
    Schilling RJ; Mitra AK
    Pharm Res; 1991 Jun; 8(6):721-7. PubMed ID: 2062801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin degradation products from perfused rat kidney.
    Duckworth WC; Hamel FG; Liepnieks J; Peavy D; Frank B; Rabkin R
    Am J Physiol; 1989 Feb; 256(2 Pt 1):E208-14. PubMed ID: 2645781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The characterization of endosomal insulin degradation intermediates and their sequence of production.
    Seabright PJ; Smith GD
    Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):947-56. PubMed ID: 9003385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Processing and presentation of insulin. II. Evidence for intracellular, plasma membrane-associated and extracellular degradation of human insulin by antigen-presenting B cells.
    Semple JW; Ellis J; Delovitch TL
    J Immunol; 1989 Jun; 142(12):4184-93. PubMed ID: 2656861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of a novel biotinylated photoreactive insulin for receptor analysis.
    Fabry M; Brandenburg D
    Biol Chem Hoppe Seyler; 1992 Mar; 373(3):143-50. PubMed ID: 1586454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The preparation and characterization of mono-iodinated photoreactive analogs of insulin.
    Heidenreich KA; Yip CC; Frank BH; Olefsky JM
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1138-45. PubMed ID: 3884003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Degradation of insulin by insulin-degrading enzyme and biological characteristics of its fragments.
    Yonezawa K; Yokono K; Yaso S; Hari J; Amano K; Kawase Y; Sakamoto T; Shii K; Imamura Y; Baba S
    Endocrinology; 1986 May; 118(5):1989-96. PubMed ID: 3516656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of insulin domains important for binding to and degradation by endosomal acidic insulinase.
    Authier F; Danielsen GM; Kouach M; Briand G; Chauvet G
    Endocrinology; 2001 Jan; 142(1):276-89. PubMed ID: 11145591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparative reversed-phase high-performance liquid chromatography of iodinated insulin retaining full biological activity.
    Linde S; Welinder BS; Hansen B; Sonne O
    J Chromatogr; 1986 Nov; 369(2):327-39. PubMed ID: 3543039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Separation, isolation and characterization of the four monoiodinated insulin tracers using reversed-phase high-performance liquid chromatography.
    Welinder BS; Linde S; Hansen B
    J Chromatogr; 1983 Aug; 265(2):301-9. PubMed ID: 6355130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 125I-insulin metabolism by rat liver cells: preferential binding and degradation of insulin labeled at TyrA14.
    Misbin RI; Buynitzky SJ; Almira EC
    Drug Metab Dispos; 1982; 10(2):153-5. PubMed ID: 6124401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding affinity of monoiodinated insulin tracers isolated after reversed-phase high-performance liquid chromatography.
    Welinder BS; Linde S; Hansen B; Sonne O
    J Chromatogr; 1983 Dec; 281():167-77. PubMed ID: 6365938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the human insulin receptor.
    Fabry M; Brandenburg D
    Biol Chem Hoppe Seyler; 1992 Sep; 373(9):915-23. PubMed ID: 1466789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homogeneous mono-(125)i-insulins. Preparation and characterization of mono-(125)i-(tyr a14)-and mono-(125)i-(tyr a19)-insulin.
    Jørgensen KH; Larsen UD
    Diabetologia; 1980; 19(6):546-54. PubMed ID: 7007134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.
    Linde S; Hansen B; Sonne O; Holst JJ; Gliemann J
    Diabetes; 1981 Jan; 30(1):1-8. PubMed ID: 7014299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms involved in degradation of human insulin by cytosolic fractions of human, monkey, and rat liver.
    Wroblewski VJ; Masnyk M; Khambatta SS; Becker GW
    Diabetes; 1992 Apr; 41(4):539-47. PubMed ID: 1607078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin degradation into monocytes from normal subjects: a high performance liquid chromatographic analysis.
    Benzi L; Marchetti P; Brunetti A; Ciccarone AM; Cecchetti P; Trischitta E; Di Cianni G; Squatrito S; Navalesi R
    J Endocrinol Invest; 1988 Apr; 11(4):303-7. PubMed ID: 3045192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential insulin degradation in cultured fetal hepatocytes in relation to chloroquine-dependent events.
    Zachayus JL; Khan S; Plas C
    Am J Physiol; 1996 Sep; 271(3 Pt 1):E417-25. PubMed ID: 8843733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.